Author name: cultivate(MD)

nanochon news

cultivate(MD) Capital Funds LP Announce Investment into Nanochon

Press Release /

Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that they have made a significant investment into Nanochon, a Washington, D.C.—based regenerative cartilage innovator. Nanochon develops solutions utilized by sports medicine physicians to treat active patients requiring […]

cultivate(MD) Capital Funds LP Announce Investment into Nanochon Read More »

SentiAR is a cultivate(MD) portfolio company

cultivate(MD) Capital Funds Portfolio Company SentiAR Announces Second FDA Clearance for CommandEP™ Interface

Press Release /

Grand Rapids, Mich., October 23, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that one of their portfolio companies, St. Louis, Missouri-based SentiAR, Inc., a pioneer in using Augmented Reality (AR) visualization technology for cardiac ablation procedures, has received their second

cultivate(MD) Capital Funds Portfolio Company SentiAR Announces Second FDA Clearance for CommandEP™ Interface Read More »

Shoulder Innovations

Shoulder Innovations Announces Placement of New CFO and New VP of Commercial Development

Press Release /

Grand Rapids, Mich., September 29, 2023—Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market announced today that they have hired Mr. Jeff Points as Chief Financial Officer. Mr. Points has 25 years of finance experience in high-growth organizations, most recently as Chief Financial Officer at Cardiovascular Systems where he

Shoulder Innovations Announces Placement of New CFO and New VP of Commercial Development Read More »

Virtual Incision cultivate(MD)

Virtual Incision Extends Series C Round with Additional $30M Funding

News /

LINCOLN, Neb.–(BUSINESS WIRE)– Virtual Incision Corporation, the developer of the world’s first miniaturized robotic-assisted surgery (RAS) system, announced a $30 million extension to its previous $46 million Series C financing. The round was led by current investors Bluestem Capital, Endeavour Vision, Baird Capital, cultivate(MD) Capital Funds, and PrairieGold Venture Partners, as well as new health-tech

Virtual Incision Extends Series C Round with Additional $30M Funding Read More »

Shoulder Innovations

Shoulder Innovations Announces Securing of a $45M Debt Facility

Press Release /

Grand Rapids, Mich., August 22nd, 2023 — Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan-based leader in the shoulder replacement implant market, announced securing of a $45M debt facility in partnership with Trinity Capital. This is in addition to SI’s recent $42M Series D equity financing, which closed earlier this year. Following the successful launch of its highly

Shoulder Innovations Announces Securing of a $45M Debt Facility Read More »

HAPPE Spine cultivate(MD) news

HAPPE Spine Announces First Clinical Use of the INTEGRATE®-C Interbody Fusion System

Press Release /

Grand Rapids, Mich., August 14, 2023—HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at the Beacon Health System – Memorial Hospital in South Bend, Indiana. Dr. Smith said, “The Integrate-C handled extremely well and went right to work. The

HAPPE Spine Announces First Clinical Use of the INTEGRATE®-C Interbody Fusion System Read More »

Virtual Incision cultivate(MD)

cultivate (MD) Capital Funds Portfolio Company Virtual Incision Submits FDA De Novo Request for Market Authorization of MIRA

Press Release /

Grand Rapids, Mich., May 22, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Lincoln, Nebraska-based Virtual Incision Corporation, has submitted a De Novo request to the U.S. Food and Drug Administration (FDA) to market its MIRA Surgical

cultivate (MD) Capital Funds Portfolio Company Virtual Incision Submits FDA De Novo Request for Market Authorization of MIRA Read More »

Start typing and press enter to search